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Abstract
The health-promoting effects of exercise training (ET) are related to nitric oxide (NO) production and/or its bioavailability. The 
objective of this study was to determine whether single nucleotide polymorphism of the endothelial NO synthase (eNOS) gene 
at positions -786T>C, G894T (Glu298Asp) and at the variable number of tandem repeat (VNTR) Intron 4b/a would interfere with 
the cardiometabolic responses of postmenopausal women submitted to physical training. Forty-nine postmenopausal women 
were trained in sessions of 30-40 min, 3 days a week for 8 weeks. Genotypes, oxidative stress status and cardiometabolic 
parameters were then evaluated in a double-blind design. Both systolic and diastolic blood pressure values were significantly 
reduced after ET, which was genotype-independent. However, women without eNOS gene polymorphism at position -786T>C 
(TT genotype) and Intron 4b/a (bb genotype) presented a better reduction of total cholesterol levels (-786T>C: before = 213 ± 
12.1, after = 159.8 ± 14.4, Δ = -24.9% and Intron 4b/a: before = 211.8 ± 7.4, after = 180.12 ± 6.4 mg/dL, Δ = -15%), and LDL 
cholesterol (-786T>C: before = 146.1 ± 13.3, after = 82.8 ± 9.2, Δ = -43.3% and Intron 4b/a: before = 143.2 ± 8, after = 102.7 ± 
5.8 mg/dL, Δ = -28.3%) in response to ET compared to those who carried the mutant allele. Superoxide dismutase activity was 
significantly increased in trained women whereas no changes were observed in malondialdehyde levels. Women without eNOS 
gene polymorphism at position -786T>C and Intron 4b/a showed a greater reduction of plasma cholesterol levels in response to 
ET. Furthermore, no genotype influence was observed on arterial blood pressure or oxidative stress status in this population.
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Epidemiological studies have shown that the incidence 
of cardiovascular disease (CVD) increases in women af-
ter menopause, and dyslipidemia, arterial hypertension, 
diabetes mellitus, physical inactivity, and weight gain are 
considered as the main risk factors for CVD in this popula-
tion (1). Conversely, exercise training has been considered 
to be an important tool in preventing as well as managing 
cardiovascular and endocrine-metabolic diseases (2). Ac-
cordingly, the health-beneficial effect of physical exercise 
is related to an increase of nitric oxide (NO) production 
(by up-regulation of endothelial NO synthase, eNOS) and/
or decrease of NO inactivation (mainly by up-regulation 
of superoxide dismutase, SOD) (3,4). Nevertheless, the 
mechanisms by which shear stress induced by physical 
exercise promotes alterations in gene expression, especially 
in eNOS and SOD activities, are not fully understood (5). 
Since NO plays a key role in the cardiovascular sys-
tem by regulating vascular tone, platelet aggregation, and 
vascular smooth muscle growth (6), a number of studies 
have examined the relationship between genetic variations 
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in the eNOS gene and cardiovascular diseases (7-9). Indeed, 
the presence of single nucleotide polymorphisms (SNPs) at 
position -786T>C and in exon 7 G894T (Glu298Asp) as well 
as at the variable number of tandem repeat (VNTR) Intron 
4b/a of the eNOS gene has been associated with a reduction 
in plasma NO levels, decreased eNOS expression or reduced 
enzyme activity, which in turn were positively associated with 
coronary spasm and arterial hypertension (10,11). On the other 
hand, some studies have failed to find a positive relationship 
between polymorphisms and cardiovascular disease. In fact, 
no measurable differences were found in nitrite/nitrate levels 
(NOx-) in subjects with eNOS gene polymorphism carrying 
a mutant allele under basal conditions (12,13). Recently, we 
showed that plasma NOx- levels were similar under basal 
conditions in postmenopausal women with or without eNOS 
gene polymorphism at position -786T>C (14).
It has also been reported that genetic variations in the eNOS 
gene are implicated in the genesis of endocrine-metabolic 
diseases such as insulin resistance, type 2 diabetes mellitus, 
higher plasma-oxidized low-density lipoprotein (LDL), and 
metabolic syndrome (15-18). Since exercise training exerts 
beneficial effects on both the cardiovascular and endocrine-
metabolic systems and that these health-promoting effects are 
strongly related to NO production and/or its bioavailability to 
the tissues, the objective of the present study was to determine 
whether SNP of the eNOS gene at positions -786T>C and 
G894T (Glu298Asp) as well as at VNTR Intron 4b/a would 
interfere with the cardiovascular and metabolic parameters 
in response to an exercise training program in postmeno-
pausal women. Therefore, in the present study we tested the 
hypothesis that postmenopausal women without eNOS gene 
polymorphism at position -786T>C, G894T (Glu298Asp) and 
Intron 4b/a would be more responsive to the beneficial effect 
of exercise training than those who carry the mutant alleles.
Material and Methods
Participant screening
The study was approved by the Institutional Review Board 
of Universidade Estadual Paulista (UNESP). Volunteers from 
the community were recruited by advertisements in the Campus 
of UNESP and surrounding area. To be included in the study, 
women had to be sedentary, non-smoking, non-diabetic (fast-
ing glucose level <100 mg/dL), never treated with hormone 
replacement therapy, in the postmenopausal age, and having 
no medical condition that would exclude exercise training. The 
exclusion criteria were subjects with cardiovascular disease 
(angina, valvular disease, stroke), arthritis, alcohol consumption 
>3 drinks per day, orthopedic conditions, or any serious medical 
condition that prevented the participants from adhering to the 
protocol or from exercising safely. To detect cardiovascular, 
pulmonary or other disease the volunteers were examined by 
a physician. A questionnaire was applied to the participants 
before the inclusion in this study reporting medical, exercise 
training and dietary data. Eligible subjects were informed of 
the procedures and risks of the study and signed a written 
informed consent in accordance with the policies and with 
the Ethics Committee of the Institute of Bioscience, UNESP 
(Rio Claro). 
Anthropometric and cardiovascular parameters 
Height was measured with a clinical stadiometer with the 
subject barefoot and body weight was measured with a cali-
brated digital precision scale (Thinner MS-7400, USA). Body 
mass index (BMI) was determined as weight (kg) divided 
by height in meters squared. Waist circumference was also 
determined. Women were instructed not to exercise outside 
the laboratory before blood pressure measurement. After 15 
min of seated quiet rest, blood pressure was measured by 
auscultation with aneroid sphygmomanometer (Tycos, USA) 
in three sessions. 
Cardiorespiratory capacity and exercise training
In the first week, the participants performed 30 min of 
physical exercise at 50% of maximum heart rate (HR), so that 
they could become familiar with the cycle ergometer. Individual 
exercise prescription was determined by a prior aerobic capacity 
evaluation as previously described (19). Briefly, each subject 
was asked to describe her habitual physical activity and her 
fitness level was determined based on this description. Initial 
work loads of 50/75 W were used and if the HR values for the 
5th and 6th min did not differ by more than 5 bpm and if their 
mean values were between 130 and 170 bpm, the test was 
stopped. If mean HR was less than 130 bpm, the work load 
was increased and the exercise test was continued. After that, 
the predicted VO2 max was determined from the nomogram 
and multiplied by correction factors (body weight and age). 
The maximal HR was calculated according to the following 
equation: 220 - age. The reserve HR (rHR) was calculated 
according to the following equation (20): rHR = [(maximal HR 
- rest HR) x % of intensity] + rest HR.
The exercise training program started with appropriate 
warm-up and cool-down activities. All exercise sessions were 
performed under the supervision of a physical trainer. Subjects 
were submitted to an aerobic exercise program on a cycle 
ergometer (Moviment, Brazil) in a quiet room with temperature 
at 25°C. Exercise training was performed for 3 days a week, 
each session consisting of 30-40 min over an 8-week period. 
In the initial 4 weeks, the intensity of training was that which 
produced 50-60% of rHR. An adjustment of the intensity of the 
exercise training program was done for 4 additional weeks (60-
70% of rHR). The protocol design is schematically illustrated 
in Figure 1.
Lipid profile and fasting glucose
Venous blood samples (6 mL) were collected after 12 h of 
overnight fasting and serum was separated by centrifugation. 
LDL cholesterol (LDL-C; Wiener, Argentina), high-density lipo-
protein cholesterol (HDL-C), total cholesterol, triglycerides, and 
glucose levels were measured enzymatically with commercial 
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colorimetric kits (LaborLab, Brazil). The atherogenic index was 
calculated by dividing total cholesterol by HDL-C levels. Values 
were considered to be elevated when LDL-C (≥130 mg/dL), 
HDL-C (<50 mg/dL for women), total cholesterol (≥200 mg/dL), 
triglycerides (≥150 mg/dL), and glucose (≥100 mg/dL). 
Determination of plasma nitrite/nitrate (NOx-) levels 
In order to evaluate NO production, the plasma levels 
of nitrite (NO2-) and nitrate (NO3-) were measured. Briefly, 
immediately after arterial blood collection, the samples were 
centrifuged at 8000 g for 10 min, and the resulting plasma 
supernatant was stored at -80°C. Plasma samples were 
ultra-filtered through microfilter cups (Microcon Centrifugal 
Filter Units, 10 kDa; Millipore, USA). The NOx- concentration 
of the resulting filtrate solution was determined by ELISA 
using a commercially available kit (Cayman Chemical Co., 
USA) according to manufacturer instructions. This assay 
determines the total NO based on the enzymatic conversion 
of nitrate to nitrite by nitrate reductase. After conversion, 
the spectrophotometric measurement of nitrite is performed 
using the Griess reaction. The resulting deep purple azo 
compound absorbs light at 540 nm. 
Plasma SOD and malondialdehyde (MDA) levels
Blood samples were centrifuged at 8000 g for 10 min and 
the plasma supernatant was ultrafiltered through microfilter 
cups (Microcon Centrifugal Filter Units, 10 kDa; Millipore). 
The white buffy layer was removed and discarded. The 
supernatant was collected and kept in ice for assaying. 
Samples, standards and radical detector were prepared 
and processed as described in commercial kits (SOD as-
say kit and plasma MDA kit, Cayman Chemical Co.). The 
assays were performed in duplicate using different sample 
dilutions. 
Genotype determination
Genomic DNA was extracted from leukocytes of blood 
cells by the chloroform-phenol method and the eNOS 
-786T>C, G894T (Glu298Asp) and Intron 4b/a sites were 
determined as described previously. The polymerase 
chain reaction (PCR) cycling conditions were 1 cycle at 
96°C for 2 min followed by 35 cycles of denaturation at 
96°C for 30 s, annealing at 60°C for 30 s and extension 
at 72°C for 1 min; ending with extension at 72°C for 5 min 
for all positions.
-786T>C
Genotyping for the eNOS -786 region was performed 
using PCR amplification with flanking primers: sense: 
5’-CACCCAGGCCCACCCCAACT-3’; antisense: 5’-GC-
CGCAGGTCGACAGAGAGACT-3’ (21). The amplicon was 
digested for 5 min at 37°C using 2 U Fast MspI enzyme 
followed by electrophoresis for 3 h on 2.5% agarose gel. 
The T allele yields a fragment of 394 bp and the C allele 
yields fragments of 352 and 42 bp.
G894T (Glu298Asp)
The 298 eNOS gene region was amplified by the PCR using 
the following flanking primers: sense: 5’-AAGGCAGGAGAC 
AGTGGATGGA-3’; antisense: 5’-CCCAGTCAATCCCTTTGG 
TGCTCA-3’ (22). The amplicon was digested overnight at 37°C 
using 2 U MboI enzyme followed by electrophoresis for 3 h on 
2.5% agarose gel. The G allele yields a fragment of 248 bp 
and the T allele yields fragments of 190 and 58 bp.
Intron 4b/a
Subjects were genotyped for the eNOS 27-bp repeat region 
in Intron 4b/a by PCR amplification with the following flanking 
primers: sense: 5’-FAM-AGGCCCTATGGTAGTGCCTTG-3’; 
antisense: 5’-TCTCTTAGTGCTGTGGTCACAG-3’, according 
to Ref. 22, slightly modified. Genotyping was performed with a 
MegaBACE™ (USA), sequencer and the results were analyzed 
using the Fragment Profiler (USA) software version 1.2. The 
4a allele generated a fragment of 393 bp and the 4b allele a 
fragment of 420 bp. 
Genotype characterization was performed after 2 months 
of exercise training in a double-blind fashion for both volunteers 
and researchers. 
Statistical analysis
Descriptive statistics for continuous variables consisted of 
the determination of central tendency and dispersion indicators, 
which are reported as means + SEM. The distribution of geno-
types for each polymorphism (Hardy-Weinberg equilibrium) and 
pharmacologic therapy were assessed using the chi-square (χ2) 
test. The paired and unpaired Student t-tests were used to ana-
lyze the effect of exercise training within each group (baseline 
and after exercise training) and the difference between groups 
(non-polymorphism and polymorphic group), respectively. 
A P value <0.05 was accepted as significant.
Results
The distribution of genotypes for the three polymor-
Figure 1. Schematic presentation of the protocol design em-
ployed for a training program applied to 49 postmenopausal 
women. HR = heart rate; HRr = reserve HR.
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phisms showed no deviation from Hardy-Weinberg equi-
librium with allele frequencies of 0.73, 0.55, and 0.67 for 
T, G, and 4b at position -786T>C, G894T (Glu298Asp), 
and Intron 4b/a, respectively. Correspondingly, the allele 
frequency for C, T, and 4a were 0.16, 0.02, and 0.02, re-
spectively. Forty-nine postmenopausal women with a mean 
age of 50.3 ± 0.92 years were studied in a double-blind 
design. Exercise training for 8 weeks did not modify BMI 
(25.50 ± 0.39 kg/m2) as compared to the baseline (25.46 
± 0.39 kg/m2), whereas waist circumference values were 
reduced in trained postmenopausal women (84.43 ± 1.07 
cm) as compared to baseline values (85.96 ± 1.11 cm), 
approximately 2%. Similarly, the cardiorespiratory capac-
ity was markedly increased after aerobic exercise training 
(32.99 ± 1.13 mL·kg-1·min-1) as compared to baseline values 
(27.07 ± 0.99 mL·kg-1·min-1) by approximately 22%, showing 
the effectiveness of the exercise training employed in this 
study. Table 1 shows the values of systolic and diastolic 
blood pressure, glycemia, lipid profile, plasma NOx- levels, 
SOD activity, and MDA levels before and after 8 weeks of 
exercise training in the overall samples. Exercise training 
was effective in promoting a significant reduction in arte-
rial blood pressure, total cholesterol, LDL-C, as well as an 
increase in HDL-C and SOD activity. No changes were 
found in glycemia, triglycerides, NOx-, 
or MDA levels when we analyzed the 
population as a whole before and after 
exercise training.
After eNOS genotype analysis, 
postmenopausal women were di-
vided into three groups according to 
the presence of SNPs at positions 
-786T>C, G894T (Glu298Asp) and 
the VNTR Intron 4b/a. Subsequently, 
the volunteers were subdivided into 
non-polymorphic groups [-786: TT (N = 
13), Glu298Asp: GG (N = 27), Intron 4: 
bb (N = 31)], and polymorphic groups 
-786: TC+CC (N = 36), Glu298Asp: 
GT+TT (N = 22), Intron 4: ba+aa (N = 
18)]. The genotype distribution for the 
polymorphic groups was 73.4% for 
-786 TC+CC, 44.8% for Glu298Asp 
GT+TT and 36.7% for Intron 4 ba+aa. 
The incidence of chronic diseases and 
pharmacologic therapy was genotype 
independent for dyslipidemia [-786T>C 
(TT: 6.1 and TC+CC: 4.1%); G894T 
(GG: 6.1 and GT+TT: 4.1%); Intron 4 
(bb: 4.1 and ba+aa: 6.1%)].
Cardiovascular parameters, 
physical training and eNOS gene 
polymorphism
Table 2 shows systolic and diastolic 
Table 1. Effect of aerobic exercise training on cardiometabolic 
parameters of post-menopausal women.
Before After Δ%
SBP (mmHg) 113.07 ± 1.59 107.13 ± 1.50* -5.2
DBP (mmHg) 74.57 ± 1.16 69.20 ± 1.09* -7.2
Glycemia (mg/dL) 85.33 ± 2.03 82.71 ± 1.66 -3.07
TG (mg/dL) 110.26 ± 9.01 105.18 ± 6.30 -4.6
TC (mg/dL) 208.27 ± 5.85 183.47 ± 5.18* -11.9
HDL-C (mg/dL) 65.06 ± 1.78 73.51 ± 1.97* -12.98
LDL-C (mg/dL) 141.10 ± 6.06 107.80 ± 4.96* -23.6
NOx- (µM) 19.48 ± 2.32 23.14 ± 2.51 18.8
SOD (U/mL) 4.86 ± 0.23 5.68 ± 0.24* 16.9
MDA (µM) 5.81 ± 0.33 5.65 ± 0.24 -2.75
Data are reported as means ± SEM before and after 8 weeks 
of aerobic exercise training for 49 women. SBP = systolic blood 
pressure; DBP = diastolic blood pressure; TG = triglycerides; TC 
= total cholesterol; LDL-C = low-density lipoprotein cholesterol; 
HDL-C = high-density lipoprotein cholesterol; NOx- = plasma ni-
trite/nitrate levels; SOD = superoxide dismutase activity; MDA = 
malondialdehyde. *P < 0.05, compared with before intervention 
(paired Student t-test).
Table 2. Effect of 8 weeks aerobic training on blood pressure and plasma nitrite/nitrate 
levels of 49 postmenopausal women with or without polymorphism for the eNOS gene at 
positions -786T>C, Glu298Asp and Intron 4b/a. 
Before After Δ% Before After Δ%
-786T>C
TT (N = 13) TC+CC (N = 36)
SBP 113.78 ± 3.59 105.36 ± 2.63* -7.4 112.81 ± 1.77 107.77 ± 1.82* -4.5
DBP 75.14 ± 2.38 68.78 ± 2.16* -8.5 74.36 ± 1.34 69.35 ± 1.28* -6.7
NOx- 21.99 ± 5.13 21.07 ± 4.38 -4.2 18.55 ± 2.59 23.91 ± 3.06 28.9
Glu298Asp
GG (N = 27) GT+TT (N = 22)
SBP 112.56 ± 1.92 106.83 ± 2.00*  -5.1 113.70 ± 2.70 107.49 ± 2.31* -5.5
DBP 73.98 ± 1.57 68.81 ± 1.40*  -7.0 75.29 ± 1.75 69.67 ± 1.75* -7.5
NOx- 21.82 ± 3.54 25.43 ± 3.73 16.5 16.72 ± 2.84 20.43 ± 3.26 22.2
Intron 4b/a
bb (N = 31) ba+aa (N = 18)
SBP 112.73 ± 2.16 107.64 ± 1.82*  -4.5 113.66 ± 2.27 106.24 ± 2.68* -6.5
DBP 74.06 ± 1.36 69.49 ± 1.30*  -6.2 75.44 ± 2.16 68.70 ± 1.99* -8.9
NOx- 19.88 ± 3.10 23.25 ± 3.47 17.0 18.81 ± 3.50 22.95 ± 3.51 22.0
Data are reported as means ± SEM. TT, GG, and bb = non-polymorphic; TC+CC, GT+TT, 
and ba+aa = with polymorphism for the eNOS gene; SBP, DBP = systolic and diastolic 
blood pressure, respectively (mmHg); NOx- = plasma nitrite/nitrate levels (µM). *P < 
0.05, compared with before intervention (paired Student t-test).
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blood pressure values and plasma 
NOx- levels before and after 8 weeks 
of exercise training in postmeno-
pausal women according to the 
eNOS genotypes. Aerobic physical 
exercise promoted a significant re-
duction in both systolic and diastolic 
blood pressure in all groups (-786T>C, 
G894T (Glu298Asp) and Intron 4b/a), 
which was genotype-independent. 
Regarding plasma NOx- levels, we 
observed that the presence of eNOS 
gene polymorphism did not alter the 
basal values in postmenopausal 
women. Furthermore, 8 weeks of 
exercise training did not affect the 
plasma NOx- levels in any of the 
three groups (-786T>C, G894T 
(Glu298Asp) and Intron 4b/a). 
Glycemia, lipid profile, physical 
training, and eNOS gene 
polymorphism
Exercise training for 8 weeks did 
not alter blood glucose or triglyceride 
levels in any of the groups studied. 
On the other hand, HDL-C levels 
were significantly increased in all 
groups in a similar fashion (ranging 
between 11.8 up to 16.5%, see Table 
3 for more details). Regarding the in-
fluence of eNOS gene polymorphism 
on plasma total cholesterol and 
LDL-C levels in response to exercise 
training, we can see that women 
without polymorphism at position 
-786T>C and Intron 4b/a were more 
responsive to the beneficial effect of 
exercise training compared to those who carried genetic 
variations (Table 3 and Figure 2). On the other hand, the 
presence of eNOS gene polymorphism at position G894T 
(Glu298Asp) did not affect the beneficial effect of exercise 
training in reducing total cholesterol and LDL-C levels in 
postmenopausal women (Table 3 and Figure 2). Further-
more, trained postmenopausal women without eNOS gene 
polymorphism at position -786T>C and Intron 4b/a showed 
a decrease in atherogenic index compared to those who 
carried the mutant alleles. However, this reduction was not 
statistically significant (Figure 2). 
Oxidative stress status, physical training and eNOS 
gene polymorphism
Plasma levels of SOD and MDA, markers of antioxidant 
and oxidant status, respectively, did not differ between 
groups under basal conditions. After 8 weeks of exercise 
training, we observed a significant increase in plasma 
SOD levels in all groups studied, which was genotype-
independent. On the other hand, exercise training did not 
affect plasma MDA levels in postmenopausal women. All 
data are summarized in Table 4. 
Discussion
The present study examined the effect of aerobic ex-
ercise training on the arterial blood pressure, lipid profile 
and redox state of postmenopausal women without or with 
eNOS gene polymorphism at position -786T>C, G894T 
(Glu298Asp) and Intron 4b/a. Our findings show that 8 
weeks of physical training were effective in reducing systolic 
and diastolic blood pressure values in postmenopausal 
women, an effect that was genotype-independent. On the 
other hand, women without eNOS gene polymorphism at 
position -786T>C and Intron 4b/a showed a greater reduc-
Table 3. Effect of 8 weeks aerobic exercise training on plasma lipids of postmenopausal 
women with or without polymorphism for the eNOS gene at positions -786T>C, Glu298Asp 
and Intron 4b/a.
Before After Δ% Before After Δ%
-786T>C
TT (N = 13) TC+CC (N = 36)
Glycemia 86.1 ± 4.3 85.4 ± 3.6 -0.8 85.1 ± 2.3 81.8 ± 1.8 -3.8
TG 106 ± 14.4 99.9 ± 10.7 -5.6 111.8 ± 11.1 107 ± 7.7 -4.3
TC 213 ± 12.1 159.8 ± 14.4* -24.9 206.6 ± 6.7 192 ± 5.8 -7.0
LDL-C 146.1 ± 13.3 82.8 ± 9.2* -43.3 139.3 ± 6.8 116.8 ± 5.2* -16.2
HDL-C 64.0 ± 3.9 74.6 ± 3.8* 16.5 65.4 ± 2.5 73.1 ± 2.2* 11.8
Glu298Asp
GG (N = 27) GT+TT (N = 22)
Glycemia 83.9 ± 2.9 82.6 ± 2.5 -1.5 87.3 ± 2.6 83 ± 2 -5.0
TG 114.5 ± 13.5 111.7 ± 9.8 -2.4 105 ± 11.5 97 ± 7 -7.6
TC 207.8 ± 7.9 181.5 ± 7.2* -12.7 208.8 ± 8.9 185.9 ± 7.6* -11.0
LDL-C 140.5 ± 8.4 105 ± 7* -25.3 141.9 ± 8.8 111.2 ± 7.0* -21.6
HDL-C 67.4 ± 2.4 76.5 ± 2.8* 13.5 61.9 ± 2.4 69.5 ± 2.8* 12.2
Intron 4b/a
bb (N = 31) ba+aa (N = 18)
Glycemia 85.4 ± 2.5 81.7 ± 1.9 -4.4 85.2 ± 3.6 85 ± 3.3 0.0
TG 97.9 ± 8.1 97.2 ± 6.9 -0.7 130 ± 18.9 117.9 ± 11.7 -9.3
TC 211.8 ± 7.4 180.12 ± 6.4* -15.0 202.2 ± 9.5 189.2 ± 8.8 -6.4
LDL-C 143.2 ± 8 102.7 ± 5.8* -28.3 137.4 ± 9.2 116.5 ± 8.8 -15.2
HDL-C 65.3 ± 2.3 74.0 ± 2.6* 13.4 64.7 ± 2.9 72.7 ± 2.9 12.3
Data are reported as means ± SEM in mg/dL. TT, GG, and bb = non-polymorphic; TC+CC, 
GT+TT and ba+aa = with polymorphism for eNOS gene; TG = triglycerides; TC = total 
cholesterol; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein 
cholesterol. *P < 0.05, compared with before intervention (paired Student t-test). 
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tion of total plasma cholesterol and LDL-C in response to 
8 weeks of exercise training than those who carried the 
mutant allele.
The relationship between eNOS gene polymorphism 
and the incidence of CVD has been studied in different 
populations (9-11). However, the data for the three most 
studied eNOS polymorphisms, T-786C, G894T and Intron 
4b/a, are not yet conclusive (12). Evidence has shown 
that physically active subjects have more longevity with 
less morbidity and mortality (23,24). Confirming previous 
studies, in the present investigation, we observed that a 
8-week exercise training was effective in lowering both 
systolic and diastolic blood pressure in postmenopausal 
women. On the other hand, we found no relationship be-
tween the beneficial effects of 8 weeks of exercise training 
in lowering arterial blood pressure and the presence of the 
eNOS gene polymorphisms -786T>C, G894T (Glu298Asp) 
and Intron 4b/a in postmenopausal women. Interestingly, 
a previous study from our laboratory showed that women 
without eNOS polymorphism at position -786T>C were more 
responsive in lowering arterial blood pressure than those 
who carried allele C (14). The reason for this discrepancy 
might be the duration of the exercise training program. 
Indeed, in the present study, we employed only 8 weeks 
as compared to the previous one that was performed over 
a period of 24 weeks. Furthermore, previous studies have 
demonstrated that the volume of exercise training is more 
important in favoring health-promoting effects than its 
intensity (25,26). 
Regarding lipid profile, the presence of eNOS polymor-
phism at position -786T>C and Intron 4b/a clearly influenced 
the beneficial effects of exercise training on the total choles-
terol and LDL-C levels. Even though the atherogenic index 
did not differ significantly between the time before and after 
exercise training in both position -786T>C and Intron 4b/a, 
when comparing the TT and TC+CC groups and bb and 
ba+aa groups, we observed a tendency of this index to be 
lower in postmenopausal women with eNOS polymorphism 
Figure 2. Effect of exercise training for 8 weeks on plasma total cholesterol and LDL cholesterol levels 
and atherogenic index of postmenopausal women without eNOS gene polymorphism (left panels) or with 
eNOS gene polymorphism (right panels) at positions -786T>C, Glu298Asp, and Intron 4b/a. Data are 
reported as means ± SEM for 49 women.
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compared to those who did not carry the mutant allele. The 
number of volunteers in the TT (N = 13) and ba+aa (N = 
18) groups compared to the number of volunteers in the 
TC+CC (N = 36) and bb (N = 31) groups was probably the 
reason for this lack of difference. Regarding the magnitude 
of reduction of total cholesterol and LDL-C in women who 
carried the eNOS gene polymorphism at position G894T 
(Glu298Asp), we observed no changes between the GG 
and GT+TT groups. The reason for this is not clear at the 
present time. Indeed, few studies exist evaluating the 
influence of eNOS gene polymorphism on the lipid profile 
in human populations. To our knowledge, only two studies 
exist analyzing this issue and the results are contradictory. 
A previous study showed a positive relationship between 
the presence of the eNOS polymorphism at position G894T 
(Glu298asp) and alterations in lipid profile in men (27). In 
contrast, another study failed to find a relationship between 
eNOS polymorphism at position G894T (Glu298asp) and 
changing in blood flow in response to statins (28). Thus, 
the present study is the first to examine the influence of the 
three most studied eNOS gene polymorphisms [-786T>C, 
G894T (Glu298Asp) and Intron 4b/a] on the lipid profile. 
Considering the relevance of exercise training in prevent-
ing or improving the deleterious effects of chronic diseases 
such as dyslipidemia and atherosclerosis, our data sup-
port our hypothesis that eNOS polymorphism at position 
-786T>C and Intron 4b/a interferes with the beneficial effects 
of 8 weeks of exercise training on cardiometabolic diseases 
in postmenopausal women. 
Regarding oxidative stress status, our data confirm 
previous results from our laboratory using an experimental 
model (29,30) showing that aerobic exercise promotes an 
improvement of antioxidant status by increasing plasma 
SOD levels, which in turn can ameliorate vascular and 
metabolic functions. In contrast, no change was found 
in thiobarbituric acid-reactive species concentrations in 
plasma measured as MDA in this particular population, 
showing that 8 weeks of exercise training did not modify 
the oxidant status. Furthermore, eNOS gene polymorphism 
does not influence the oxidative stress status under basal 
conditions. Our data agree with a previous study that showed 
that eNOS gene polymorphism at position -786T>C had no 
influence on the MDA levels of young subjects (31). 
It is important to critically evaluate the limitations of our 
study. There are two limitations that need to be taken into ac-
count, i.e., the number of volunteers and the duration of the 
exercise training program. However, these limitations can 
be seen as an important window for future research under 
the same theme since the role of genetics and of physical 
exercise is relevant for the health of the population. 
Thus, the novelty of the present study is that we ex-
amined the effect of the three most studied eNOS gene 
Table 4. Plasma superoxide dismutase activity (SOD, U/mL) and malondialdehyde levels 
(MDA, µM) before and after 8 weeks of aerobic exercise training by postmenopausal women 
with or without polymorphism for eNOS gene at position -786T>C, Glu298Asp and Intron 
4b/a. 
Before After Δ% Before After Δ%
-786T>C
TT (N = 13) TC+CC (N = 36)
SOD 4.91 ± 0.53 5.83 ± 0.36* 18.7 4.84 ± 0.24 5.62 ± 0.30* 16.1
MDA 6.33 ± 0.53 5.77 ± 0.52 -8.8 5.60 ± 0.42 5.59 ± 0.29 -0.2
Glu298Asp
GG (N = 27) GT+TT (N = 22)
SOD 5.06 ± 0.28 5.78 ± 0.30* 14.2 4.62 ± 0.37 5.54 ± 0.39* -19.9
MDA 5.64 ± 0.33 5.26 ± 0.30 -6.7 5.98 ± 0.59 6.03 ± 0.36 0.8
Intron 4b/a
bb (N = 31) ba+aa (N = 18)
SOD 4.94 ± 0.30 5.58 ± 0.33 13.0 4.73 ± 0.35 5.85 ± 0.32* 23.7
MDA 5.58 ± 0.42 5.91 ± 0.29 -5.4 6.15 ± 0.55 5.25 ± 0.42 -14.6
Data are reported as means ± SEM. TT, GG, and bb = non-polymorphic; TC+CC, GT+TT, 
and ba+aa = with polymorphism for eNOS gene. *P < 0.05, compared with before interven-
tion (paired Student t-test).
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polymorphisms on the cardiometabolic responses of 
postmenopausal women submitted to 8 weeks of exercise 
training. Our findings showed that the presence of eNOS 
gene polymorphism at position -786T>C and Intron 4b/a 
provoked a lower reduction in cholesterol levels in response 
to physical exercise suggesting that more attention should 
be given to this population regarding preventive actions 
related to plasma lipid control. Indeed, dyslipidemia is the 
primary cause of endocrine-metabolic disorders, which 
results in clinical outcomes such as myocardial infarction, 
stroke and peripheral artery disease and most postmeno-
pausal women have lipid profile alterations (1). Therefore, 
preventive actions changing lifestyle for women’s health 
are crucial since women live longer than men and effective 
prevention could decrease the high cost of the health care 
system for this population. 
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